Company

Septerna

Rocket Ship Rating

Rocket Ship Rating: 96 out of 100

Pioneering a New Era of GPCR Drug Discovery.

Also known as Septerna, Inc.

Biotech & therapeutics

Status: Operatingas of 2026-09-18Source (opens in a new tab)
Business model: B2B
Legal name: Septerna, Inc.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Septerna is a biotechnology company powered by our proprietary Native Complex Platform®

Funding snapshot

Total raised: $73.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $73.5M2023-06-28

Funding rounds

Round, 2023: $73.5M2023-06-28, SEC form D sold, 30 investors